Novozymes on Novozymes: The Digest’s Multi-Slide Guide to Novozymes’ Q2 results

August 10, 2016 |

In Denmark, Novozymes reported its Q2 earnings and updated its outlook for the rest of 2016. Headlines?  Sales grew by 3% organically in the first half, EBIT was on par, and the EBIT margin was 27.2%, also on par with the first half of 2015. Restructuring costs hit the EBIT margins. Profit was up nicely.

What’s in Novozymes’ near-term roadmap? Here’s the Q2 presentation given this week by CEO Peder Holk Nielsen to investors.



Prev1 of 11
Use your ← → (arrow) keys to browse

Print Friendly, PDF & Email


Category: 8-Slide Guide

Thank you for visting the Digest.